Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life;Prevalencia de déficit de hierro sin anemia en la enfermedad inflamatoria intestinal y su impacto en la calidad de vida

Gastroenterologia y Hepatologia

Volumn 41, Issue 1, 2018, Pages 22-29

  González Alayón, Carlos ^a   Pedrajas Crespo, Carolina ^a   Marín Pedrosa, Sandra ^a   Benítez, José Manuel ^a   Iglesias Flores, Eva ^a   Salgueiro Rodríguez, Isabel ^a   Medina Medina, Rosario ^a   García Sánchez, Valle ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Anaemia; Health related quality of life; Inflammatory bowel disease; Iron deficiency

Indexed keywords

FERRITIN; HEMOGLOBIN; TRANSFERRIN; IRON;

ARTICLE; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; FATIGUE; FERRITIN BLOOD LEVEL; GENDER; HEALTH IMPACT ASSESSMENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; IRON DEFICIENCY; OBSERVATIONAL STUDY; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; ADULT; BLOOD; DEFICIENCY; DIARRHEA; FEMALE; MALE; METABOLISM; MIDDLE AGED; PSYCHOLOGY;

ADULT; CROSS-SECTIONAL STUDIES; DIARRHEA; FATIGUE; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; INFLAMMATORY BOWEL DISEASES; IRON; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; TRANSFERRIN;

EID: 85028909802     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2017.07.011     Document Type: Article

References (29)

1. Gasche, C., Anemia in IBD: the overlooked villain. Inflamm Bowel Dis 6 (2000), 142–150 discussion 51.
2. Kulnigg, S., Gasche, C., Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 24:11–12 (2006), 1507–1523.
3. Gisbert, J.P., Gomollon, F., Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 103 (2008), 1299–1307.
4. Gasche, C., Berstad, A., Befrits, R., Beglinger, C., Dignass, A., Erichsen, K., et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel DisV 13, 2007, 1545–1553.
5. Hindryckx, P., Amininejad, L., van De Vijver, E., Bossuyt, P., Belgian recommendations for the management of anemia in patients with inflammatory bowel disease. Acta Gastroenterol Belg 77 (2014), 333–344.
6. Dignass, A.U., Gasche, C., Bettenworth, D., Birgegard, G., Danese, S., Gisbert, J.P., European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis 9 (2015), 211–222.
7. de la Morena, F., Gisbert, J.P., Prevalencia y características de la anemia enpacientes con enfermedad inflamatoria intestinal. Gastroenterol Hepatol, 32, 2009, 223.
8. Ott, C., Liebold, A., Takses, A., Strauch, U.G., Obermeier, F., High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort. Gastroenterol Res Pract, 2012, 2012 595970.
9. Gomollon, F., Gisbert, J.P., Anemia and inflammatory bowel diseases. World J Gastroenterol 15 (2009), 4659–4665.
10. Wilson, A., Reyes, E., Ofman, J., Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med, 116(Suppl 7A), 2004 44s-9s.
11. Casellas, F., López-Vivancos, J., Casado, A., Malagelada, J.R., Factor affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res 11 (2002), 775–781.
12. Cella, D., The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Scale: Summary of development and validation. 2003, Center on Outcomes. Research and Education (CORE), Evanston Northwestern Healthcare and Northwestern University, Evanston, IL.
13. Alcala, M.J., Casellas, F., Fontanet, G., Prieto, L., Malagelada, J.R., Shortened questionnaire on quality of life for inflammatory bowel disease. Inflamm Bowel Dis 10 (2004), 383–391.
14. Bager, P., Befrits, R., Wikman, O., Lindgren, S., Moum, B., Hjortswang, H., et al. Fatigue in out patients with inflammatory bowel disease is common and multifactorial. Aliment Pharmacol Ther 35 (2012), 133–141.
15. Herrera-deGuise, C., Casellas, F., Robles, V., Navarro, E., Borruel, N., Iron deficiency in the absence or anemia impairs the perception of health-related quality of life of patients with inflammatory bowel disease. Infamm Bowel Dis. 22 (2016), 1450–1455.
16. Cohen, B., Zoega, H., Shah, S., Leleiko, N., Lidofsky, S., Bright, R., et al. Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity. Aliment Pharmacol Ther 39 (2014), 811–822.
17. Goldenberg, B.A., Graff, L.A., Clara, I., Zarychanski, R., Walker, J.R., Carr, R., et al. Is iron deficiency in the absence of anemia associated with fatigue in inflammatory bowel disease&quest. Am J Gastroenterol 108 (2013), 1392–1397.
18. Lennard-Jones, J.E., Classification of inflammatory bowel disease. Scand J Gastroenterol, 170(2–6), 1989 discussion 16-9.
19. Satsangi, J., Silverberg, M.S., Vermeire, S., Colombel, J.F., The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55 (2006), 749–753.
20. De Roy, P., Helsinki and the Declaration of Helsinki. World Med J. 50 (2004), 9–11.
21. WHO. INT. Micronutrient Deficiencies: iron deficiency anemia (IDA). 2015.
22. Hervada Vidal, X., Santiago Pérez, M.I., Vázquez Fernández, E., Castillo Salgado, C., Loyola Elizondo, E., Silva Ayçaguer, L.C., Epidat 3.0: programa para análisis epidemiológico de datos tabulados. Rev Esp Salud Pública 78 (2004), 277–280.
23. Lakatos, L., Pandur, T., David, G., Balogh, Z., Kuronya, P., Tollas, A., et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 9 (2003), 2300–2307.
24. Oldenburg, B., Koningsberger, J., van Berge Henegouwen, G., van Asbeck, B., Marx, J., Iron and inflammatory bowel disease. Aliment Pharmacol Ther 15 (2001), 429–438.
25. Rupp, I., Boshuizen, H.C., Jacobi, C.E., Dinant, H.J., van den Bos, G.A., Impact of fatigue on health related quality of life in rheumatoid arthritis. Arthritis Rheum 51 (2004), 578–585.
26. van Langenberg, D.R., Gibson, P.R., Systematic review: fatigue in inflammatory bowel disease. Aliment Pharmacol Ther 32 (2010), 131–143.
27. Verdon, F., Burnand, B., Stubi, C.F., Bonard, C., Graff, M., Michaud, A., et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. Bmj, 326, 2003, 1124.
28. Anker, S.D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Eng J Med 361 (2009), 2436–2448.
29. Evstatiev, R., Alexeeva, O., Bokemeyer, B., Chopey, I., Felder, M., Gudehus, M., et al. Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 11 (2013), 269–277.